MARKET

CGC

CGC

Canopy Growth
NASDAQ

Real-time Quotes | Nasdaq Last Sale

24.72
+1.00
+4.22%
Pre Market: 26.45 +1.73 +7.00% 07:01 11/24 EST
OPEN
23.93
PREV CLOSE
23.72
HIGH
25.06
LOW
23.68
VOLUME
20.27K
TURNOVER
--
52 WEEK HIGH
26.95
52 WEEK LOW
9.00
MARKET CAP
9.20B
P/E (TTM)
-7.4003
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
IIPR, IBD Stock Of The Day, Offers Multiple Entries As Marijuana Stocks Shape Up
Innovative Industrial Properties is the IBD Stock of the Day. IIPR stock has been trading tightly over the past few weeks.  
Investor's Business Daily · 17h ago
Canopy Growth announces long-term effects of cannabidiol in the preclinical model C. elegans
Canopy Growth (CGC) announces that cannabidiol ((CBD)) did not demonstrate any degree of acute or life-long toxicity or related liabilities at physiological concentrations.Instead, CBD extended mean lifespan up to 18% and
Seekingalpha · 22h ago
Canopy Growth announces completion of study on the long-term effects of CBD
Study represents the first research completed on the long-term toxicity and lifespan effects of cannabidiol in the preclinical model C. elegans SMITHS FALLS, ON, Nov.
CNW Group · 1d ago
Worm Study Shows CBD Science Has a Way to Go: Cannabis Weekly
Bloomberg · 1d ago
Cannabis industry has 30-40% more upside, pot ETF issuer says after Joe Biden victory
Cannabis ETFs have a bright year ahead following Joe Biden's presidential win, investor Tim Seymour says.
CNBC.com · 2d ago
Cannabis Stocks Watchlist: Tilray and Canopy Growth Fall
See how Cannabis stocks performed in the market this week along with buy, hold and sell recommendations by TheStreet Quant Ratings.
TheStreet.com · 2d ago
Why the Bull Run in Canopy Growth Will Last
InvestorPlace · 3d ago
Is This The Best Way To Play The Second Boom In Marijuana?
Hopes of nationwide legalization have triggered another rally in cannabis shares, and this time it’s all about big data, science and boosting market share
Oilprice.com · 4d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CGC. Analyze the recent business situations of Canopy Growth through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CGC stock price target is 20.25 with a high estimate of 29.05 and a low estimate of 13.76.
EPS
Institutional Holdings
Institutions: 439
Institutional Holdings: 37.98M
% Owned: 10.20%
Shares Outstanding: 372.28M
TypeInstitutionsShares
Increased
95
5.23M
New
106
-8.55K
Decreased
79
1.73M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.87%
Pharmaceuticals & Medical Research
-0.36%
Key Executives
Chairman/Independent Director
Judy Schmeling
President
Rade Kovacevic
Chief Executive Officer/Director
David Klein
Chief Financial Officer/Executive Vice President
Mike Lee
Senior Vice President
Thomas Shipley
Vice President/IR Contact Officer
Judy Hong
Chief Accounting Officer/Vice President
Thomas Stewart
Other
Phillip Shaer
Director
Jimes Sabia
Independent Director
Robert Hanson
Independent Director
David Lazzarato
Independent Director
William Newlands
Director
Terry Yanofsky
Independent Director
Theresa Yanofsky
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CGC
Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Canopy Growth Corp stock information, including NASDAQ:CGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CGC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CGC stock methods without spending real money on the virtual paper trading platform.